Centre made interim allocation of Tocilizumab to states
By IANS |
2 Views
New Delhi, April 28 : As limited stock of Tocilizumab is available in the country, the Centre has made interim allocation of injection to the states.
In letter dated April 27 to states, Joint Secretary, Department of Pharmaceuticals, Navdeep Rinwa Aand Rajiv Wadhawan wrote, The drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in Covid-19 cases in the country in this month.
They further wrote that fresh limited stock of this drug has now been imported and is available with the lone marketer company Cipla Limited for marketing and distribution in the country.
The Union government has made an interim allocation of tocilizumab among the states, as a fresh limited stock of the drug used for the treatment of COVID-19 patients has arrived in the country. In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country. Fresh limited stock of this drug has now been imported and is available with lone marketer company Cipla Ltd formarketing and distribution in the country, the letter said.
Govt makes interim allocation of COVID-19 treatment drug Tocilizumab to states
Fresh limited stock of this drug has now been imported and is available with lone marketer company Cipla Ltd for marketing and distribution in the country, the letter said.
Share Via Email
| A+A A- By PTI
NEW DELHI: The Union government has made an interim allocation of Tocilizumab among the states, as a fresh limited stock of the drug used for the treatment of COVID-19 patients has arrived in the country.
In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country.
Centre releases treatment procedure for COVID-19 patients, advises proning for self care
The ministry, in a document, said proning is the process of turning a patient with precise, safe motions, from their back onto their abdomen so that the individual is lying face down.
Share Via Email
| A+A A-
A health worker inspects COVID-19 patients undergoing treatment at Shehnai Banquet Hall, converted into an isolation centre amid surge in coronavirus cases, near LNJP Hospital in Delhi. (Photo | PTI) By PTI
NEW DELHI: The Union health ministry on Thursday advised proning for self care for coronavirus patients, stating that it is extremely beneficial for such patients with compromised breathing comfort, especially during home isolation.
The Union health ministry on Thursday issued a revised Clinical Guidance for Management of Adult COVID-19 Patients recommending the EUA/off-label use of Tocilizumab drug in case of severe diseases, preferably within 24 to 48 hours of the onset of the disease or ICU admission. The guidelines issued by AIIMS, ICMR-COVID-19 National Task Force and the Joint Monitoring Group (DGHS) under the ministry stated that Tocilizumab (a drug that modifies the immune system or its functioning) may be considered in patients with significantly raised inflammatory markers and not improving despite use of steroids with there being no active bacterial/fungal/tubercular infection.